Regadenoson Real Time Perfusion Imaging Trial-Optison

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01489176
Recruitment Status : Unknown
Verified September 2012 by Thomas R. Porter, MD, University of Nebraska.
Recruitment status was:  Recruiting
First Posted : December 9, 2011
Last Update Posted : September 26, 2012
Astellas Pharma US, Inc.
GE Healthcare
Information provided by (Responsible Party):
Thomas R. Porter, MD, University of Nebraska

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2013
  Estimated Study Completion Date : September 2013